KPMG Partners with Hippocratic AI to Enhance Global Healthcare Through AI-Powered Clinical Agents

KPMG International and Hippocratic AI have announced a groundbreaking collaboration aimed at transforming healthcare delivery through the use of generative AI healthcare agents. This partnership is particularly timely given the significant workforce shortage in the healthcare sector, which is projected to reach 10 million workers by 2030. By deploying Hippocratic AI’s conversational agents, the initiative seeks to alleviate pressure on healthcare systems, optimize processes, and enhance patient outcomes. Hippocratic AI, a leader in developing safety-first generative AI healthcare agents, has designed these agents to perform non-diagnostic clinical tasks, such as patient intake and follow-up calls. These AI agents can interact with patients in a natural, intuitive manner, comprehending and responding to human conversation in a contextually relevant and human-like way. This approach frees up healthcare providers to focus more on direct patient care, thus addressing the pressing issue of staffing shortages and workload pressures. The collaboration involves KPMG’s global healthcare professionals conducting comprehensive process analyses to identify high-pressure areas within healthcare systems. They will also upskill the workforce to ensure seamless integration of AI agents and strategically plan for their deployment across the entire care continuum. This holistic approach aims to maximize the benefits of AI while minimizing potential disruptions, ensuring that both AI and human staff work harmoniously to improve efficiency and quality of care. Munjal Shah, Founder and CEO of Hippocratic AI, highlighted the purpose and vision driving the partnership: “Our collaboration with KPMG is deeply aligned in improving patient outcomes and optimizing healthcare efficiency. KPMG’s commitment to driving meaningful impact across the entire care journey ensures that AI augmentation preserves the human touch of clinicians and the integrity of healthcare operations.” Dr. Anna van Poucke, KPMG Global Healthcare Leader, emphasized the importance of a coherent strategy to unlock the full potential of AI in healthcare: “As societies age, the healthcare workforce shortage poses a significant risk to the continuity of care. Hippocratic AI’s generative AI healthcare agents can mitigate these risks, but their effective implementation requires transforming operational processes and empowering clinical staff to work seamlessly with their AI counterparts.” The initial success of Hippocratic AI’s agents in North America has seen them complete over 2.49 million patient calls, achieving an average satisfaction rating of 8.95 out of 10. This success has paved the way for further expansion, with recent launches in the UAE, Japan, and UK, indicating the company's global reach and potential impact. To put this collaboration into context, it builds on KPMG’s previous work in AI-driven healthcare solutions. For example, their "digital oncology" solution, which provided clinical information and context-based recommendations, resulted in a 50% increase in patient satisfaction, a 27% decrease in staff workloads, and a 78% increase in staff satisfaction. These results underscore the potential of AI to significantly enhance healthcare delivery and patient experiences. Industry insiders view this partnership as a pivotal step in the evolution of healthcare. The combination of KPMG’s expertise in process transformation and strategic planning, along with Hippocratic AI’s cutting-edge technology, is poised to set new standards in the sector. Investors, including prominent firms like Andreessen Horowitz and General Catalyst, are optimistic about the potential for global healthcare improvement through the deployment of safe, effective AI agents. Hippocratic AI was co-founded by CEO Munjal Shah and a team of experts from institutions such as El Camino Health, Johns Hopkins, Stanford, and tech giants Microsoft, Google, and NVIDIA. The company has secured $278 million in funding, reflecting the high confidence in its mission and technology. KPMG, with its extensive network of 275,000 partners and employees across 143 countries, brings a global perspective and the resources needed to scale this transformative technology effectively. In summary, the collaboration between KPMG and Hippocratic AI represents a significant advancement in addressing healthcare workforce shortages and enhancing patient care. By leveraging AI to perform non-diagnostic clinical tasks, the partnership aims to create a more efficient and responsive healthcare system, ultimately improving outcomes for both patients and healthcare providers. Industry experts see this as a strategic move that could redefine the future of healthcare delivery.